Preview

Journal Biomed

Advanced search

Состояние клеточной β-адренорецепции при артериальной гипертонии и ее модификация на фоне лечения различными формами β-адреноблокатора метопролола

About the Authors

О. Манешина
ГОУ ВПО РГМУ, Москва
Russian Federation


М. Леонова
ГОУ ВПО РГМУ, Москва
Russian Federation


Ю. Белоусов
ГОУ ВПО РГМУ, Москва
Russian Federation


А. Духанин
ГОУ ВПО РГМУ, Москва
Russian Federation


References

1. Lücker P, Moore G, Wiselgren I, et al. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses. J Clin Pharmacol 1990; 30 (Suppl): S17-27

2. Plosker GL, Clissold SP. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease. Drugs 1992; 43 (3): 382-414.

3. Zineh I <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Zineh+I%22%5BAuthor%5D>, Beitelshees AL <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Beitelshees+AL%22%5BAuthor%5D>, Gaedigk A <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Gaedigk+A%22%5BAuthor%5D>, Walker JR <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Walker+JR%22%5BAuthor%5D>, Pauly DF <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Pauly+DF%22%5BAuthor%5D>, Eberst K <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Eberst+K%22%5BAuthor%5D>, Leeder JS <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Leeder+JS%22%5BAuthor%5D>, Phillips MS <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Phillips+MS%22%5BAuthor%5D>, Gelfand CA <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Gelfand+CA%22%5BAuthor%5D>, Johnson JA <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Johnson+JA%22%5BAuthor%5D>. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension. Clin Pharmacol Ther. <javascript:AL_get(this,%20'jour',%20'Clin%20Pharmacol%20Ther.');> 2004 Dec;76(6):536-44.


Review

For citations:


 ,  ,  ,   . Journal Biomed. 2006;1(3):50-52. (In Russ.)

Views: 156


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5982 (Print)
ISSN 2713-0428 (Online)